ArticleBMC medicine2018
Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?
Article in BMC medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Older adult care efficiency and health outcomes: a meta-analysis of the Chinese and Japanese experiences.Frontiers in public health · 2025Pooled it
- Observational
- Premature mortality projection for cardiovascular diseases to 2030: a sub-national evaluation towards the SDG 3.4 goals in China.The Lancet regional health. Western Pacific · 2026Article
- Epigenetics, bacterial metabolites and type 2 diabetes: a new view of gut-genome interactions.Frontiers in microbiology · 2026Review
- Latent profile analysis and influencing factors of kinesiophobia among young and middle-aged patients with coronary heart disease.Frontiers in medicine · 2026Article
- Environmental and ethnic differences in short-term risk of first acute myocardial infarction: a prospective multiethnic cohort protocol.Frontiers in public health · 2026Article
- Expert consensus statement for basic research of animal exercise intervention studies in chronic disease prevention and treatment: A joint position paper of the Exercise Science branch of the Biophysical Society of China and the Metabolism and Genetics branch of the Genetics Society of China.Journal of sport and health science · 2025Article
- Enhancing national fitness legislation in the context of promoting a healthy China.Frontiers in sports and active living · 2025Review
- In-patient expenditure between 2011 and 2021 for patients with type 2 diabetes mellitus: a hospital-based multicenter retrospective study in southwest China.Frontiers in public health · 2025Article
- China is actively implementing health impact assessment legislation.Frontiers in public health · 2025Article
- Article
- Temporal Trends in Cardiovascular Health Status Among Chinese School-Aged Children From 1989 to 2018: Multiwave Cross-Sectional Analysis.JMIR public health and surveillance · 2023Article
- Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis.BMC public health · 2023Article
- The Mediation Effect of Perceived Attitudes toward Medical Service on the Association between Public Satisfaction with the Overall Medical Service and Self-Rated Health among the General Population in China: A Cross-Sectional Study.International journal of environmental research and public health · 2023Article
- Effects of Intergenerational Care Behavior on Residents' Nutrition Intake-Descriptive Statistical Analysis of Rural China Survey 2010-2014.Foods (Basel, Switzerland) · 2022Article
- Heat maps of cardiovascular disease risk factor clustering among community-dwelling older people in Xinjiang: a cross-sectional study.BMJ open · 2022Article
- Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021.Frontiers in cardiovascular medicine · 2022Review
- Article
- Advance for Cardiovascular Health in China.Journal of cardiovascular translational research · 2019Review
- Exploring the evolution of eHealth in disease management: A bibliometric analysis from 1999 to 2023.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases (CVDs) represent the leading cause of death in China. The Chinese government approved the Healthy China 2030 plan (jiànkāng zhōngguó 2030), emphasizing the strategic role of health in China's development. As morbidity and mortality from CVDs are constantly increasing in China, the prevention and treatment of CVDs are vital to achieve this plan. Following the major principles of health priority, science and technology innovation, scientific development, and balanced medical resource allocation outlined in the Healthy China 2030 plan, this Commentary briefly introduces the current status of CVDs in China and marks the important events undertaken to achieve this plan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.